Oral Corticosteroids Tapering in Severe Asthma
- PMID: 33211979
- PMCID: PMC8017580
- DOI: 10.1164/rccm.202010-4001ED
Oral Corticosteroids Tapering in Severe Asthma
Comment on
-
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.Am J Respir Crit Care Med. 2021 Apr 1;203(7):871-881. doi: 10.1164/rccm.202007-2721OC. Am J Respir Crit Care Med. 2021. PMID: 33112646
References
-
- Global Initiative for Asthma. Global Initiative for Asthma. 2020 accessed 2021 Jan 19]. Available from: www.ginasthma.org.
-
- Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52:1800703. - PubMed
-
- Bourdin A, Molinari N, Vachier I, Pahus L, Suehs C, Chanez P. Mortality: a neglected outcome in OCS-treated severe asthma. Eur Respir J. 2017;50:1701486. - PubMed
-
- Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141:110–116, e7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical